CLINICAL

Samsung Gets First U.S. ApprovalThe second Remicade biosimilar is only the fifth biosimilar approved in the United States.
What You Need to Know About the NABP Annual MeetingThe 113th Annual Meeting will feature CPE, discussions, and more.
Cherokee Nation Sues CVS, Walgreens, and Others Over Opioids
Cherokee Nation Sues CVS, Walgreens, and Others Over OpioidsDid major chain pharmacies and distributors contribute to the opioid epidemic in Oklahoma?
A Big Shift for a Major PBMAnthem is parting ways with Express Scripts.
New NACDS Chairman Stresses Pro-Customer Leadership RoleNACDS’s Gourlay embraces leading the industry proactively through changing health-care industry.
NACDS’ New CourseExpanded scope-of-practice/health-and-wellness figure prominently in new strategy.
NACDS Elects Officers/New Members to Board/Executive CommitteeThe latest news from the 2017 NACDS annual meeting.
Pharmacists Joining the March for Science
Pharmacists Joining the March for SciencePharmacists and pharmacy groups are taking part in a national march in support for science.
Is $485 million enough to end the opioid epidemic?
Is $485 million enough to end the opioid epidemic?The HHS is giving out greatly needed funds, but money alone may not be enough.
FDA Issues New Label Change for Codeine and Tramadol
FDA Issues New Label Change for Codeine and TramadolDecades of research has led to a flurry of new warnings.

Poll